Innovative Chemical Approach Revitalizes Malaria Drug Effectiveness
Researchers have pioneered a chemical modification that enhances the solubility and efficacy of a malaria drug, offering new hope against resistant strains. Learn how this breakthrough could revolutionize malaria treatment.
Researchers at the University of California, San Francisco, have discovered a novel chemical modification that transforms a once-failing malaria medication into a potent, easy-to-administer drug. Malaria remains a global health challenge, claiming approximately 600,000 lives annually, predominantly children in Sub-Saharan Africa. The increasing resistance of the malaria parasite to existing treatments has necessitated the development of new therapies.
The team focused on artefenomel, an artemisinin-inspired compound originally designed to replace combination therapies due to its potential to cure malaria with a single dose. However, clinical trials revealed significant challenges: artefenomel's high symmetry caused it to form crystals, hindering its dissolution and making it difficult to develop as a practical oral pill. It also proved problematic in pediatric treatments, where the suspension form was hard for children to swallow and ensure accurate dosing.
To address these issues, scientists manipulated the molecular structure, reducing its symmetry to prevent crystallization and enhance solubility. The modified molecules dissolved instantaneously in water, facilitating easier formulation into pills. Subsequent testing confirmed that these new compounds remained highly effective against malaria parasites, including strains resistant to artemisinin, and could be produced inexpensively.
This breakthrough offers hope for more effective, accessible malaria treatments, especially critical as resistance spreads into Africa, where most cases and fatalities occur. The findings suggest that simple chemical tweaks can revitalize existing drugs, providing a new path forward in the fight against resistant malaria strains.
The research has been published in Science Advances and signifies a promising step towards developing more reliable and straightforward antimalarial medications.
Source: https://medicalxpress.com/news/2025-08-chemical-malaria-drug-winner.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Increase in Obamacare Premiums Expected in Florida Next Year
Expect a major rise in Obamacare premiums in Florida next year as pandemic-era subsidies expire, potentially affecting millions of low- and middle-income enrollees. Learn about the implications for healthcare costs and access.
Uncovering the Brain's Role in Circadian Regulation and Jet Lag Adaptation
Deep brain imaging reveals the complex neuronal networks within the suprachiasmatic nucleus that regulate our internal clock and influence how we adapt to jet lag, opening new possibilities for circadian rhythm therapies.
Higher Risk of Opioid Overdose Deaths Among Female and Minority Veterans
Research reveals that female veterans and racial/ethnic minority groups are at greater risk of dying from opioid overdoses, highlighting urgent needs for targeted interventions.
Lymph Nodes Play a Crucial Role in Enhancing Cancer Immunotherapy Effectiveness
New research reveals the pivotal role of lymph nodes in enhancing the effectiveness of cancer immunotherapy by supporting immune cell development and function, suggesting potential improvements in treatment strategies.